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A B S T R A C T
Integrative structural biology combines data from multiple experimental techniques to generate complete
structural models for the biological system of interest. Most commonly cross-linking data sets are employed
alongside electron microscopy maps, crystallographic structures, and other data by computational methods that
integrate all known information and produce structural models at a level of resolution that is appropriate to the
input data. The precision of these modelled solutions is limited by the sparseness of cross-links observed, the
length of the cross-linking reagent, the ambiguity arisen from the presence of multiple copies of the same
protein, and structural and compositional heterogeneity. In recent years integrative structural biology ap-
proaches have been successfully applied to a range of RNA polymerase II complexes. Here we will provide a
general background to integrative structural biology, a description of how it should be practically implemented
and how it has furthered our understanding of the biology of large transcriptional assemblies. Finally, in the
context of recent breakthroughs in microscope and direct electron detector technology, where increasingly EM is
capable of resolving structural features directly without the aid of other structural techniques, we will discuss the
future role of integrative structural techniques.
1. Introduction
The goal of structural biology is to derive detailed functional and
mechanistic information on a biomolecule from the arrangement of its
constituent atoms. Since their introduction in the 20th century the two
techniques at the forefront of structural biology, X-ray crystallography
and electron microscopy (EM), have undergone seismic changes leading
to an explosion in the numbers of scientists practicing structural biology
and the pursuit of biological targets of ever-increasing complexity. X-
ray crystallography has trended from focusing on small soluble proteins
and individual protein domains [1–3] to large multi-subunit complexes
and challenging membrane-associated targets [4–7]. In contrast elec-
tron microscopy has seen an evolution from massive, highly symme-
trical macromolecules [8,9], to ever-smaller and asymmetric targets
[10]. This evolution reflects an important underlying principle of
biology; namely, that biological processes often occur in the context of
large and asymmetrical protein, lipid-associated or nucleoprotein as-
semblies. The function of these assemblies is often dependent on a large
set of more transient biomolecule interactions and on significant levels
of domain motion, which act as sources of compositional and con-
formational heterogeneity, respectively. Such biological heterogeneity
has provided significant technological challenges and has frequently
exposed the limitations of individual structural biology techniques. For
example, the formation of a highly populated and ordered macro-
molecular crystal lattice, which forms the basis for high-resolution X-
ray diffraction data, is dependent on the deposition of a population of
macromolecules that are identical in respect to both their composition
and conformation. Sources of heterogeneity lead to lattice ‘poisoning’
that attenuate the intensity of useful Bragg diffraction. Likewise, in the
context of electron micrographs, which capture images of individual
macromolecules with low signal-to-noise, sources of macromolecular
heterogeneity lead to increased errors in the assignment of projection
angle [11,12] and put extra demands on the computational routines
designed to separate particles into distinct structural classes [13].
Due to this limitation of individual structural techniques, studies of
large macromolecular assemblies have often been limited to distinct
subassemblies, which suffer less from problems due to heterogeneity
and therefore can be solved at higher resolution. Integrative structural
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biology approaches were developed to overcome the shortfalls of in-
dividual structural techniques and provide a framework for combining
the data from multiple structural approaches to form a more complete
picture of dynamic biological assemblies. A branch of this integrative
approach, Integrative Structural Determination (ISD), attempts to use
as much of the relevant biochemical and biophysical data about a
macromolecular complex as possible to generate three-dimensional
structures (models). ISD merges data sets that individually cannot lead
to the unambiguous (e.g. atomistic) structural determination of the
whole macromolecular complex. ISD exploits the mutual synergy and
consistency of the datasets in such a way that the resulting model
precision is higher (and therefore more informative) than the precision
of the models generated by each individual dataset. In the ISD ap-
proach, datasets are encoded into a scoring function which is able to
rank models according to how compatible they are to the input data.
The configurational space of the represented complex is then ex-
tensively and thoroughly sampled. Best-scoring models (the ensemble
of solutions) are validated and analyzed to assess their quality and build
testable hypotheses [14,15].
Importantly, two main problems can limit an effective ISD ap-
proach: the lack of data and the incomplete sampling of the models. The
former can be due to the instability of the experimental sample or
technological limitations, while the latter is related to the huge number
of degrees of freedom of large protein complexes. To overcome these
issues, the ISD approach can exploit two important principles that are
intrinsic to the hierarchical architecture of assemblies: the transferability
of datasets and the modularity of the structure (Fig. 4). The transfer-
ability assumes that the bulk of the data is robust, irrespective of the
functional state of the complex. Using this principle, one can collect
data on a functional state where the protein complex is more stable, and
use the data to model the functional state of interest. The modularity
principle assumes that the complex is formed of several stable and in-
dependent sub-complexes, whose architecture varies only modestly
upon changes in the functional state. The modularity allows in-
vestigators to assign the data to distinct components of the system in a
divide-and-conquer fashion, allowing a more efficient model sampling.
Over the last decade the ISD approach has been remarkably suc-
cessful in modeling the architectures of large, fundamentally important
complexes whose structures seemed intractable to single techniques
such as those involved in transcription (pre-initiation complex,
Mediator, TFIIH, etc.), translation (ribosome, elF3) and transit across
the nucleus (nuclear pore complex) [16–24]. Many of these applications
assumed the modularity and transferability principles.
In this review we will provide a general description of the in-
tegrative modeling pipeline and then review how it has been im-
plemented to provide novel details of a number of complexes involved
in RNA polymerase II (RNAPII) transcription. Finally, we will provide a
discussion of the future of integrative modeling in the context of recent
transformational developments in cryo-EM.
2. RNAPII transcription initiation machinery
The initiation of transcription from eukaryotic genes depends on the
assembly at gene promoters of a massive pre-initiation complex (PIC)
involving RNAPII and the general transcription factors (GTFs) TFIIA, -B,
-D, -E, -F, -H and -S. This 31-protein assembly includes proteins that
recognise and bind conserved regulatory promoter DNA elements up-
stream of the transcriptional start site, distort the DNA to direct its path
along the active site cleft of RNAPII and apply DNA helical torsion in an
ATP-dependent manner to melt the DNA duplex and promote single-
stranded template DNA binding within the RNAPII active site. The
Megadalton Mediator complex, traditionally classified as a transcrip-
tional coactivator complex, also plays an essential role in the initiation
pathway [25,26]. Mediator binds transcriptional activator proteins and
supports the stimulation of transcription at inducible gene promoters in
response to activator UAS binding [27,28]. The augmented
transcriptional response to activators depends on the integrity of the
unstructured C-terminal domain (CTD) of RNAPII [29–31], which is
highly conserved across eukaryotes and composed of tandem hepta-
peptide repeats. Mediator binds to the CTD and in doing so acts as a
bridge between cellular regulatory signals and the basal transcriptional
machinery. Mediator-RNAPII interactions are responsible for increasing
RNAPII levels and transcriptional output at gene promoters in vivo
[32,33]. Mediator binds to unmodified CTD repeats [34] and RNAPII
molecules with unmodified CTD sequence are exclusively recruited to
the PIC [35]. Upon full PIC assembly the CTD is brought together with
the CTD kinase TFIIK (a submodule of TFIIH), and the resulting CTD
phosphorylation correlates with loss of the Mediator-RNAPII interac-
tion and the transition to the elongation phase of the transcription cycle
(RNAPII promoter escape) [36,37]. A striking feature of the gene acti-
vation pathway is the modular organisation of the transcriptional ap-
paratus involved. Most of the polypeptides constituting the PIC are
members of multi-subunit sub-assemblies that must be brought together
as ‘ingredients’ for efficient transcriptional initiation. This modularity
provides ample opportunities to regulate this early stage of transcrip-
tion, such as in the example described above, where post-translational
modification of the CTD is used to regulate the stability and residency
of factors at the promoter. A further layer of regulation may exist
through the compartmentalization of the transcription apparatus into
so-called membrane-less compartments within the nucleus. Recent data
have shown that the Mediator complex plays a critical role in bridging
enhancer and promoter elements in the genome [38,39]. An emerging
view in the field is that in Metazoans the colocalization of super-en-
hancer-bound transcription factors, coactivators such as Mediator, and
the promoter-associated general transcription machinery may in part be
driven through a process termed biomolecular condensation, where
multivalent interactions involving intrinsically disordered domains
contribute to a phase-separated state producing regions with a high
local concentration of essential transcription components. Support for
this idea comes from recent observations of nuclear puncta in which
Mediator and RNAPII colocalise with super-enhancer elements in
structures that have properties of phase-separated condensates such as
sensitivity to a non-specific aliphatic alcohol, 1,6-hexanediol [40–42].
A comprehensive biochemical and structural dissection of the interac-
tion between the yeast activator Gcn4 and its Mediator target, Med15,
has described a large heterogenous “fuzzy” complex comprised of
multiple low affinity hydrophobic interactions that interact additively
in a non-specific free-for-all manner to increase the overall binding
affinity [43,44]. The fact that the activation domains of transcription
factors such as Gcn4 are archetypical intrinsically disordered regions
brings into question the contribution of the “fuzzy” hydrophobic in-
terface to the formation of membrane-less transcriptional condensates
in vivo [45].
3. Novel biological findings from integrative structural biology-
based studies of transcription complexes
3.1. Introduction to integrative structural determination
The ISD workflow follows a series of well-defined steps (Fig. 1)
[15,46]. First, all available primary data for the system of interest are
gathered (see Section 4.4 for details). Datasets generally used by ISD
include low-resolution three-dimensional EM reconstructions, small-
angle X-ray scattering (SAXS), atomic-level data for subunits or do-
mains, cross-linking mass spectrometry (CLMS), affinity pulldowns,
labeling and co-localization experiments. The second stage involves
generating a multi-scale representation of all components of the multi-
subunit assembly and translating data into spatial restraints (see
Section 4.5 for details). For certain domains in which atomistic struc-
tural information in the form of either homology models or crystal
structures are available, these regions will be represented at the atomic
or residue level as fixed rigid-body structures. Other domains will have
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no atomic resolution structural information and will be represented
with chains of coarse-grained beads, with a suitable excluded volume,
and connected by the continuity of the polypeptide chain. The third
stage in the modeling workflow involves performing exhaustive com-
putational sampling of the configurational space in order to identify a
population of model solutions that best satisfy the full set of input re-
straints (see Section 4.6 for details). In practice this is achieved by
computing parallel modeling trajectories or replicas (Replica Exchange)
[47], each starting from a randomised starting configuration. Upon
convergence of the computational sampling the ensemble of top-scoring
solutions is classified by structural similarity to detect discrete struc-
tural subpopulations (see Sections 4.7 and 4.8 for details). At this stage
subunit densities are calculated for each subpopulation cluster and in-
formation relating to how precisely each subunit in the model has been
localised can be generated and graphically represented. Also, in-
formation relating to protein domain proximities in the complex can be
extracted and graphically represented to reveal interesting biology and
form the basis for future biochemical characterisation. To validate the
resulting models a series of tests are performed that are designed to
check restraint data robustness and the completeness of sampling (see
Section 4.9 for details).
Over the last few years, we exploited the modular properties of the
transcription machinery to model the architecture of increasingly
complex transcription factor assemblies using ISD. We proceeded
hierarchically, building on structural studies of isolated subcomplexes,
and eventually characterized the large Mediator-bound PIC (Med-PIC).
3.2. Mediator Head module structure
Biochemical and structural studies have established that the
Mediator complex is composed of three modules, the Head, Middle and
Tail modules [48,49], that have a roughly equal share of the 21 sub-
units that comprise the core yeast Mediator complex. The subunit
composition of each module was defined by a combination of
Fig. 1. Representation of the multiple stages of integrative structural determination.
M.J. Trnka, et al. Methods xxx (xxxx) xxx–xxx
3
biochemical and genetic analyses [49–54]. Genetic screens for sup-
pressors of a truncated RNAPII CTD identified a number of so-called
SRB genes, five of which encoded core Mediator subunits [27,50,55].
Four of the five core Mediator SRB gene products were found to reside
in the Head module, a 220 KDa assembly of seven proteins, most of
which were found to be essential for yeast viability. Taken together
with biochemical experiments showing that the full Mediator displays a
robust CTD binding response [27,50,51], these genetic observations
suggested a functional interaction between the CTD and the Head
module with a direct interaction likely. Under non-permissive condi-
tions, conditional mutations in the largest Head module subunit, Med17
(Srb4), lead to a dramatic global reduction of mRNA levels brought
about through a destabilisation of the Mediator complex [25,26,56].
Therefore, the Mediator complex acts through the Head module to
perform an essential role in the pathway to transcriptional activation at
most eukaryotic gene promoters. A number of studies set out to eluci-
date the structural basis of Head module activities in transcription. The
structure of a Med18-Med20 complex, encoded by two of the SRB
genes, was the first atomic level information available, but provided
little framework for understanding Head module function [57]. Struc-
tural information was extended to include the full seven-subunit Head
module isolated from recombinant preparations of the yeast complex
using X-ray crystallography [58]. From the resulting 4.2 Å density maps
an architectural polyalanine model, composed mostly of alpha helices,
revealed roughly 60% of the primary sequence (PDB: 3RJ1). The
structure showed that the Head module can be divided into three in-
dependent structured domains, two termed the “Mobile Jaw” and
“Fixed Jaw” based upon EM observations [59], which are separated
from a third highly helical “Neck” domain by a mainly unstructured
“Joint” region (Fig. 2B). In the absence of full chain connectivity and
fully resolved side chain density, the very challenging job of assigning
and threading subunit sequence into the secondary structure elements
of this architectural model was guided by structure predictions and
selenomethionine difference density peaks [58].
Shortly after publication of the recombinant yeast Head module we
solved the structure of the native yeast Mediator Head module both
alone and bound to the RNAPII CTD [34]. A strong set of phases from
multiple isomorphous replacement with anomalous scattering (MIRAS)
experiments generated maps that, whilst at a similar resolution to that
achieved for the recombinant Head module, revealed features not seen
previously such as domain connectivity in the central “Joint” region
and large sections of β-sheet within both the “Neck” and the “Fixed
Jaw” domains. Within these maps elongated CTD density comprising
around four heptad repeats was found to follow a path across a highly
conserved surface of the “Neck” domain. Modeling the new Head
module density would provide a model that accounted for 80% of the
primary sequence. However, the following challenges presented them-
selves during early model-building efforts: (1) sequence assignment for
helices in subunits Med11 (“Neck”) and Med17 (“Fixed Jaw”) con-
flicted with the existing Head module structure (PDB: 3RJ1), (2) se-
quence ambiguities for inter-domain connectivity within the “Joint”
region remained. To address these challenges, we employed an in-
tegrative approach where CLMS derived distance restraints were used
to help revise sequence assignments and accurately model domain
connectivity within the “Joint” region.
Revising the Med11 sequence assignment involved correctly de-
termining the directionality of Med 11N-term helix 1 (α1) and helix 2
(α2), which are core elements in a 10-helix bundle within the “Neck”
region. Cross-links within the “Neck” were consistent only with a
Med11 assignment in which the directionality of Med11 α1 and α2
were reversed from that proposed in 3RJ1 (Fig. 2B). Such a reversal also
positioned the C-terminal end of Med11 α2 within continuous map
density that connected to the Med11 C-term, and was consistent with a
high-resolution X-ray crystal structure of an isolated Med11-Med22
four-helix bundle [60].
Revising C-terminal Med17 sequence involved, amongst other
things, determining the correct sequence connectivity between helices
that were previously modelled as unconnected elements and whose
sequence had been assigned based mostly on a sparse collection of se-
lenomethionine difference peaks. CLMS analysis supported the re-
assignment of Med17 C-terminal 597-611 and 670-685 helices and
surrounding sequence (Fig. 2B). For example, based upon the 3RJ1
Med17 sequence assignments, cross-links between Med17 K589, K601
and K608 with five surrounding lysines gave an average Cβ cross-link
distance of 40.9 Å, significantly greater than the typical violation cut-
off of 30 Å. After reassignment the average Cβ cross-link distance for
the same collection of cross-links was 20.6 Å.
A cluster of SRB mutations map to residues within the “Joint” region
of the Head module [50,55]. A first step to understanding the structural
basis of these mutations was to model this region of the structure, since
it remained completely unmodeled in 3RJ1. Despite the presence of
clear and continuous protein backbone densities, the combination of
low secondary structure content, elevated B-factors and insufficient
map resolution to position side-chain densities made “Joint” region
modeling particularly challenging. Ambiguities were resolved by in-
corporating constraints from CLMS analysis into the molecular mod-
eling workflow. A relatively large number of cross-links mapped to the
“Joint” region, with a particular concentration in a Med17 hotspot
comprised of six independent Med17 cross-links. These strong cross-
linking constraints facilitated modeling of a Med17 β-ribbon that en-
compassed most of the cross-link hotspot (Fig. 2B). Importantly, mod-
eling of this region of Med17 dramatically simplified the process of
modeling into the remaining “Joint” density. To our knowledge, this
remains a rare example of the use of cross-link constraints to interpret
X-ray crystallography maps and highlights the power of integrative
structural approaches to overcome the weaknesses inherent in in-
dividual structural approaches.
3.3. Unique architectural roles of Med17 and Med14 in the Mediator
complex
The last few years have seen huge gains in our understanding of the
organisation and molecular structure of the Mediator complex, both as
an independent complex and also when engaged with other compo-
nents of the transcriptional apparatus. Aside from the Head module and
a few isolated domains from the Middle [61,62] and Tail modules
[43,63], until very recently only a basic view of the organisation and
subunit architecture of the 21-subunit core Mediator complex was
available. Studies probing subunit interaction networks [49,64,65] as
well as subunit co-expression [53,54,66,67] and subcomplex isolation
studies [68,69] combined to determine the subunit composition of the
Mediator modules. This data was augmented by EM studies using dif-
ferent labelling strategies to coarsely map the termini of various Med-
iator subunits onto two-dimensional projection views of the complex
viewed in negative stain [70,71]. However, until very recently no three-
dimensional architectural information was available for the Middle and
Tail modules, together accounting for three quarters of the mass of the
Mediator complex.
The transition from coarse two-dimensional subunit mapping to the
first full three-dimensional Mediator model resulted from the applica-
tion of an ISD strategy to the structure of the RNAPII Holoenzyme, the
complex of Mediator and RNAPII. The Holoenzyme complex is not only
a functionally relevant form of Mediator, but is also more soluble and
stable than free Mediator alone under the conditions used for cross-
linking experiments. Using BS3 cross-linking, about 400 cross-links
were identified for the Holoenzyme. Despite the availability of a low-
resolution Mediator EM map [70], it was impossible to generate a
model of the Holoenzyme using the cross-links without a complete
Holoenzyme EM map, or a model of the Mediator using the EM map
without the cross-links. As a consequence, we envisioned an ISD
strategy for the isolated Mediator complex based on the transferability
and the modularity principles described above. First, Holoenzyme
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cross-links were transferred to the Mediator-alone structural determi-
nation, guided by the low-resolution map. Second, we enforced the
modularity principle, by segmenting the Mediator EM density map into
regions corresponding to the Head, Middle, and Tail modules of Med-
iator (Fig. 4).
The Mediator model generated by this ISD approach positioned each
subunit within the low-resolution Mediator envelope and provided an
unambiguous picture of the organisation of the Mediator Middle and
Tail modules (Fig. 2A) [17]. As well as global architectural details, the
approach provided a structural framework for interpreting the role
played by individual Mediator subunits in the complex. Central to un-
derstanding the organisation of the Mediator complex was shedding
light on the role of the two large and essential subunits Med14 and
Med17. Originally identified in a genetic screen in yeast for genes re-
quired for glucose repression [72], Med14 had been classified as a
member of both the Middle and Tail modules. Furthermore, truncation
of the C-terminal portion of Med14 was shown to destabilise the in-
teraction between these same Mediator modules [73]. Reconstitution of
a stable and functionally active human core Mediator complex (Head
and Middle subunits) was shown to depend on the presence of Med14,
suggesting an important scaffolding role within the complex [74]. By
providing the three-dimensional subunit architecture of the Mediator
complex, the ISD approach was the first to shed light on the structural
basis of the unique scaffolding role played by Med14 (Fig. 2A). Subunit
density for Med14 was mapped over a vast portion of the Mediator
complex, spanning a total distance of 220 Å. Cross-linking patterns
show that the N-terminus of Med14 is positioned to interact with
Med10 and 19 at one extreme of the Mediator Middle module whilst
central regions of Med14 encompass the remainder of the Middle. The
cross-linking pattern of the C-terminal portion of Med14 showed a
distinctive pattern characterised by colocalization with the Tail module
proteins Med15 and 16. This observation helped to localise the junction
between the Mediator Middle and Tail modules and hence explained
the loss of the Tail module in Mediator preparations harbouring a
truncation of the C-terminal portion of Med14 [73]. The proximity of
Med14 to subunits from all three Mediator modules provided strong
support to the view that Med14 plays an essential architectural role in
the complex, helping to stabilise the intermodular interactions that hold
the complex together. Recent high-resolution structural studies have
since confirmed the localisation of Med14 first provided by integrative
modeling and have provided further structural evidence for the role of
Med14 to bridge the Head, Middle and Tail modules [75–77].
Fig. 2. Novel RNAPII transcription complex biology determined using integrative structural methods. (A) Architecture of the yeast Mediator complex. Mediator
subunit localization densities (left side) determined for the free Mediator using ISD methods, docked into Med-PIC cryo-EM map (grey transparent density). Atomic
model of the yeast Head and Middle lacking Med1 (right side) from recent cryo-EM studies [77] oriented for direct comparison to the docked Mediator ISD model.
Coloured coordinate axes show the orientation of the models relative to the Med-PIC cryo-EM map (panel C). (B) Integrative structural solution of the Mediator Head
module. A cross-link dataset (left side; yellow colour) was used to guide model building into X-ray crystallographic map density at 4.2 Å resolution. Alternative view
of the Head module (right side) showing regions in which revisions to sequence assignment or novel model build were supported by CLMS distance restraints (red
colour). (C) cryo-EM structure of the complete Mediator-bound transcriptional pre-initiation complex [18]. Density for RNAPII, general transcription factors, pro-
moter DNA and individual Mediator modules is coloured to facilitate map interpretation. Coloured coordinate axes provide a reference to orient structural com-
ponents in other figure panels. (D) Integrative structural determination of TFIIK architecture. TFIIK subunits (Kin28, Tfb3 and Ccl1) were localized to novel Med-PIC
cryo-EM map density (grey mesh) by integrating CLMS and EM restraints (left side). Modeling was supported by docking of a homology model for the TFIIH ATPase
RAD3 into the cryo-EM density. Cross-links between TFIIK subunits and RAD3 together with EM restraints supported the integrative structural determination of TFIIK
subunit localisation maps (solid densities). The position of homology models that contributed to the multi-scale representations of TFIIK subunits are shown
positioned within their corresponding localization densities. Schematic representation of the inter-subunit cross-links that provided distance restraints for TFIIK
integrative modeling (right side). (E) Dynamics and GCN4 cross-linking of the Mediator Tail module. Cryo-EM map from a particle sub-population in which the
Mediator Tail module was in the ‘Tail-Up’ conformation (left side). In the ‘Tail-Up’ conformation the Tail moves closer to RNAPII and the upstream promoter DNA
with bound activators. Schematic representation of the cross-links between the activator GCN4 and its main target within Mediator, Med15. The transcriptional
activation domain and DNA-binding bZIP domain of GCN4 are indicated. The four Med15 domains known to be targets of GCN4 (KIX domain and activator binding
domains 1–3) are indicated. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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Likewise, Med17, the largest subunit in the Head module had been
shown to act as a scaffold by forming extensive interactions with nearly
all of the remaining Head module subunits. Despite playing an essential
functional role in yeast (P. Robinson unpublished results), the first
181 N-terminal residues of Med17 were unstructured and unresolved in
X-ray studies of the Mediator Head module [34,58,78]. The ISD ap-
proach provided an explanation for this missing Med17 crystallographic
density, which was found to play a critical architectural role in the
Mediator complex. The Med17 N-terminal domain (NTD) was found to
extend away from the surface of the Head module to interact closely
with a central region of the Mediator Middle module (Fig. 2A). The
Med17 NTD was mapped to this region through cross-links to the
Middle module subunits Med 7, 21, 4, 9, 14, and could be localised with
a precision of roughly 10 Å. By extending away from the Head module
to take part in an extensive interaction network with these Middle
module subunits, the Med17 NTD was predicted to play an important
bridging role between these two distinct Mediator modules. As with
Med14, later high-resolution studies confirmed the unique bridging
interactions played by Med17 within the Mediator complex [75–77]
and demonstrated that the ISD approach provided an accurate low-re-
solution model for the N-terminal region of Med17 within the Mediator
Middle module guided by a collection of CLMS distance restraints.
3.4. Middle module architecture
The fact that over half of the subunits comprising the 9-subunit,
∼300KDa Middle module are essential for yeast survival corroborates
the idea that this Mediator region plays a central role in gene activa-
tion. As for the conserved Head module, attempts to understand the
structural basis of its core biological role were initiated through the
purification and X-ray crystal structure solution of small stable domains
such as the Med7N-Med31 and Med7C-Med21 heterodimers [61,62].
However, these models accounted for only a small fraction of the pri-
mary sequence of the Middle module and in isolation they provided
little biological insight. Attempts to build a more complete picture of
the architecture of the Middle module came first from cross-linking
mass-spectrometry [79] and later from affinity labelling studies where
subunits were coarsely mapped onto 2D negative-stain EM images of
Mediator using labelled antibodies or based upon difference maps fol-
lowing subunit deletion [70,71]. Although both of these experimental
approaches provided valuable new information, neither were sufficient
to provide a complete 3D architectural view of the Middle module.
These studies had, however, made some interesting predictions as to the
arrangement of Middle module subunits. Based upon: (1) cross-link
constraints, (2) evolutionary relationships between the Med7-21 and
Med4-9 heterodimers, and (3) end-to-end helical packing interactions
observed within crystals of Med7C-Med21, Lariviere and colleagues
predicted that an extended arrangement of end-to-end stacked helical
bundles would form a central scaffold within the Middle module [79].
Later EM observations corroborated the idea of an extended Middle
module architecture but were unable to resolve the internal subunit
organisation [70,71]. Although tantalizing, these early modeling efforts
were manually derived, speculative in nature and remained un-
challenged by rigorous computational validation procedures.
A first complete 3D architectural representation of the Middle
module was produced using ISD (Fig. 2A) [17]. Crucially, this approach
differed from earlier attempts to define Middle module architecture by
being able to combine all available structural information, comprising
atomic models, comparative models, cross-link restraints and a low-
resolution EM envelope in an unbiased computational approach to ex-
haustively sample configurational space. Strikingly, the computational
approach confirmed that the elongated Middle module density was
defined by an end-to-end packing of the 4-helix Med7C-21 and Med4N-
9 heterodimers. This central scaffold was localised within the EM
density at a high level of precision, with an average root means square
fluctuation (RMSF) of around 10 Å within the cluster of top-scoring
model solutions. The architectural model provided details of the ar-
rangement of Med10 and Med19 at one extreme of the elongated
Middle module and their binding interface with the 4-helix bundle of
Med7C-21. At the other extreme the large subunits Med14 and Med1
were shown to interact on opposite surfaces of the equivalent helical
bundle formed by Med4N-9. As described above, the model also pro-
vided details of an extensive network of interactions positioned close to
the central Med7C-21/Med4N-9 junction that involves not only these
four subunits but also the N-terminal extension of the Head module
subunit Med17 and central portions of Med14. Such details provided by
the architectural model of the Middle module produced by integrative
modeling have since been validated by high resolution structural stu-
dies using X-ray crystallography and cryo-EM (Fig. 2A) [75–77]. Such
validation confirms that integrative modeling techniques can produce a
very accurate description of the internal 3D organisation of multi-sub-
unit assemblies and form a strong foundation from which to design
further structural and functional analyses.
3.5. TFIIK location in the pre-initiation complex
TIIK is a trimeric subassembly within the large multi-subunit gen-
eral transcription factor TFIIH. Whereas the remainder of TFIIH func-
tions as an ATP-dependent DNA helicase/translocase with roles in
promoter DNA opening [80] and DNA damage repair [81], the TFIIK
trimer performs a disparate role as a protein kinase. Yeast TFIIK is
composed of the cyclin-dependent kinase Kin28, its cyclin Ccl1 and a
third protein Tfb3, which together phosphorylate the C-terminal do-
main of the largest RNAPII subunit Rpb1 [82]. Phosphorylation of
Serine 5 residues within the highly conserved tandem CTD heptapep-
tide repeats correlates with disruption of the Mediator-RNAPII inter-
action at the gene promoter [37] and transition of RNAPII to the
elongation phase of the transcription cycle [38,39]. Therefore, in the
context of the promoter-associated pre-initiation complex, TFIIH si-
multaneously makes two important contributions to transcriptional
initiation: (1) ATP-dependent DNA translocase activity to melt the
duplex promoter DNA and allow engagement of the template strand in
the active cleft of RNAPII and (2) destabilisation of the PIC through
CTD phosphorylation leading to RNAPII promoter escape. Under-
standing the structural basis of these two functions and how they are
coordinated in the context of the pre-initiation complex has been a key
focus of a number of recent structural studies. The architecture of the
31-subunit PIC, lacking Mediator, was first determined using in vitro
reconstitution and cryo-EM analysis of the human [83], and subse-
quently the yeast [84] promoter assemblies. These studies demon-
strated that the PIC has a bilobal structure with one lobe comprised of
RNAPII with a number of the general transcription factors including
TBP, TFIIA, -B, and -F and the second comprised of TFIIH and regions of
TFIIE. In these studies, promoter DNA could be traced through the
structure, with large distortions introduced through interactions with
TFIIB and TBP, such that prior to DNA melting, the double stranded
DNA is directed along the active site cleft of RNAPII before exiting
along a path that allows downstream contacts with the Ssl2 translocase
subunit of TFIIH. Negative stain EM with affinity labelling [85] as well
as ISD analyses [16] had previously determined the course arrangement
of subunits within the yeast TFIIH complex. These analyses suggested
that the two TFIIH ATPase subunits Ssl2 and Rad3 are associated at
opposite ends of a central multi-subunit core (comprising Tfb1/2/4/5 &
Ssl1), with the TFIIK trimer at a more peripheral location, adjacent to
Rad3. This prior information helped to interpret TFIIH density in the
PIC cryo-EM maps and position the core and associated Ssl2 and Rad3
ATPase subunits. Ssl2, the TFIIH translocase with a prominent role in
transcriptional initiation, was positioned to interact with the down-
stream promoter DNA, and at the other end of the TFIIH core a Rad3
homology model could be unambiguously docked into corresponding
EM density [84]. However, no density was found corresponding to the
∼120KDa TFIIK trimer in the vicinity of Rad3 or otherwise, and
M.J. Trnka, et al. Methods xxx (xxxx) xxx–xxx
6
therefore TFIIK was assumed to be highly flexible and averaged out
during image processing.
The location of TFIIK within the PIC was determined using an in-
tegrative structural biology approach in which cryo-EM was combined
with CLMS and ISD to calculate and interpret EM density for an in vitro-
assembled 52-protein Mediator-bound pre-initiation complex (Fig. 2C)
[18]. Mediator and PIC EM densities could be docked into the Med-PIC
map with little evidence of structural perturbation upon complex for-
mation (Fig. 2A). However, such docking highlighted a region of PIC
density immediately adjacent to Rad3 that had not been observed in the
analysis of PIC complexes lacking Mediator. As the Mediator complex had
earlier been shown to stimulate the CTD kinase activity of TFIIK [27], and
since TFIIK was missing in the earlier PIC reconstructions [83,84], the
TFIIK trimer seemed an obvious candidate for the extra PIC density,
which appeared to become ordered upon Mediator binding. An ISD ap-
proach was used to test whether this extra density, segmented from the
Med-PIC EM map, was consistent with TFIIK cross-link restraints
(Fig. 2D). The analysis was performed by fixing the adjacent Rad3
homology model at its corresponding position in the Med-PIC EM map as
an anchor and then searching configuration space for solutions for TFIIK
subunit localisations that best satisfy both TFIIK cross-links and EM
density restraints. Importantly, all top scoring models from these trial
simulations represented a single self-consistent TFIIK subunit architecture
that localised to the extra EM density whilst fully satisfying TFIIK cross-
links. The architectural solution demonstrated that direct interactions
between Rad3 and Tfb3 likely underpin the connectivity of TFIIK to the
TFIIH core whilst proximity to subunits in the Mediator Middle and Head
modules likely play a role in positioning TFIIK in space. Localising TFIIK
within the PIC provided a clear explanation of the role of Mediator in
stimulating the CTD kinase activity of TFIIK. Unbiased docking of the
Head-CTD crystal structure within the PIC shows that Head interactions
position the CTD in the immediate vicinity of TFIIK. Therefore, the
structural evidence strongly suggests that Mediator acts to simultaneously
position both the RNAPII CTD and TFIIK trimer within the PIC and bring
them into close proximity in order to stimulate CTD kinase activity.
3.6. Tail module architecture, dynamics and activator interactions
The Tail module is composed of non-essential protein subunits with
higher levels of sequence divergence than observed within the Head and
Middle modules. Rather than contributing to the basal transcription in-
itiation mechanism the Tail module is instead responsible for mediating
the regulatory response to sequence-specific DNA-binding transcription
factors [66]. Indeed, the yeast Tail module Med2-Med3-Med15 triad has
been shown to be a common target of transcriptional activator proteins
including the extensively studied Gal4 and Gcn4 [68,86]. Studies ex-
ploring the nature of the Gcn4-Mediator interaction have described a
“fuzzy” binding mechanism whereby numerous low-specificity and low-
affinity hydrophobic interactions function additively to amplify the
overall binding affinity between activator and Mediator [43]. A recent
study combining cross-linking with NMR demonstrated that interactions
between the Gcn4 activation domains (ADs) and multiple activator-
binding domains (ABDs) within Med15 are very heterogenous in nature
with all possible AD-ABD combinations detected and contributing to a
large “fuzzy” interaction surface [44]. The generality of this binding
mechanism is still an open question but it is interesting to note that
transcriptional coactivators often harbour multiple ABDs, and such a
model could potentially explain how a collection of otherwise unrelated
transcriptional activator proteins can converge on a limited number of
transcriptional coactivator targets. A further open question is how the
transcriptional response is modulated by transcription factor-Mediator
interactions. Do such interactions simply increase the residency of Med-
PIC complexes at the gene promoter, as some have suggested [87], or
does transcription factor binding have an allosteric effect, leading to
conformational changes that modulate transcription levels? Evidence for
the latter has come from EM studies in which activator binding events
have been correlated with structural changes within the Mediator com-
plex [88]. To date, the Tail module remains the least well characterised
of the three Mediator modules. For example, high-resolution structural
studies of the Tail have been limited to a modest collection of small
protein domains [43,89]. Low-resolution mapping of subunit termini
within EM projection images provided some insight into the relative
location of the various Tail subunits, but this information was restricted
to two dimensions [70,71].
The first 3D architectural details of the Tail module were provided
alongside those for the Middle module in an ISD study describing the
subunit architecture of the full Mediator complex [17]. The model that
resulted from this study localised each Tail module subunit within the 3D
EM envelope and provided a structural explanation for the EM labelling
studies, protein-protein interaction data and sub-complex isolation ob-
servations reported previously [49,54,64,65,67–69]. In the case of the
Tail module, the architectural solution was strongly influenced by the
inclusion of a 540-residue homology model for the N-terminal portion of
Med16, identified by strong sequence similarities to the 7-bladed β-
propeller of the S. cerevisiae vesicle coat protein Sec31. Positioning of this
homology model through cross-linking and EM constraints helped to
determine the proper location of all other Tail module components.
Specifically, Med2, Med3 and Med15 that make up a Tail module triad
commonly targeted by activators, were found to colocalize with the C-
terminal region of Med14 at the junction between the Tail and Middle
modules. The N-terminal portions of Med2 and Med3, both of which are
strongly predicted to form a coiled-coil motif, were colocalized with
particularly high precision to a single region of the Tail (Fig. 3A), sup-
porting the idea of coiled-coil interactions and explaining the observation
of Med2-3-15 sub-complex isolation in earlier biochemical studies [68].
Likewise, the observed Med16 β-propeller-Med5 interface explained
earlier reports of Med5-Med16 N-term sub-complex isolation [70].
Information on the architecture and dynamics of the Tail module
was expanded in the integrative structural studies of Med-PIC, which
revealed some surprising novel features of Tail module biology
(Fig. 2E). Firstly, all prior structural studies on the Mediator complex
had suggested that only a single inter-module connection existed be-
tween the Middle and Tail modules, for which the C-terminal domain of
Med14 was shown to be a critical component [70,71]. However, evi-
dence from cryo-EM and cross-linking on Mediator-bound to the PIC
showed that in fact a second Middle-Tail connection existed and was
brought about by a direct interaction between Med1 and Med5 from the
Middle and Tail modules, respectively (Fig. 2E). Such a direct interac-
tion had been picked up in yeast two-hybrid screens but overlooked due
to a lack of supporting structural evidence [49]. Second, the Tail
module was observed in two distinct structural states. The most popu-
lated and best resolved state, termed the “Tail Down” state (Fig. 2C) has
the Med2-Med3-Med15 triad positioned a significant distance from the
upstream transcriptional activator sequences and out of range to form
cross-links to other components of the transcriptional apparatus.
However, a second lower populated state, termed the “Tail Up” state,
involves a 50 Å movement of the whole ∼450KDa Tail module toward
the upstream promoter DNA bringing the Tail in close proximity to the
back side of RNAPII (Fig. 2E). Cross-linking analysis on Med-PIC, which
in contrast to the cryo-EM, was conducted in the presence of the tran-
scriptional activator Gcn4, corroborated EM observations of a “Tail Up”
conformation with numerous Tail-RNAPII and Tail-Gcn4 cross-links
observed in the CLMS dataset. Such cross-links were only consistent
with a Tail module that had transitioned from the “Tail-down” to “Tail-
up” conformations, which raised the tantalising possibility that acti-
vator interactions may be involved in stabilising such a structural
transition. A comparison of the Tail-Gcn4 cross-link pattern observed
either within the Med-PIC complex or for isolated Gcn4 and Med15
domains, highlights some interesting points about the mechanism of
Gcn4 activation at gene promoters. The Gcn4-Med15 interaction is
driven by hydrophobic interactions between residues in the intrinsically
disordered N-terminal activation domain of Gcn4 and hydrophobic
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surfaces found within four Med15 regions, an N-terminal KIX domain
and three ABDs (Fig. 2E) [90]. Biochemical studies have scrutinised
these interactions at the primary sequence level [91] and a solution
structure of Med15 ABD1 bound by residues from the Gcn4 activation
domain demonstrated that Gcn4 residues adopt a helical conformation
upon binding to allow aromatic residues to insert into a shallow hy-
drophobic Med15 cleft [43]. Interactions between residues within the
Gcn4 activation domain and Med15 KIX domain and ABDs, have been
consistently observed both in the context of the Med-PIC complex as
well as more simple systems limited to just the Gcn4 activation domain
and truncated Med15 constructs [44]. However, cross-link analysis
within the Med-PIC assembly portrays a more complex picture for
Gcn4-Mediator interactions. Specifically, the Gcn4-Mediator cross-link
with the highest overall spectral count was not between a Gcn4 residue
within the N-terminal activation domain, but instead between a C-
terminal Gcn4 residue located at the terminus of the DNA-binding bZIP
domain. Importantly, within Mediator this cross-link mapped to Med15
ABD2, which was also found to be heavily cross-linked to Gcn4 residues
within the N-terminal activation domain, as expected. Indeed, a striking
picture emerged where residues from both the Gcn4 activation and bZIP
domains formed an overlapping pattern of cross-links within the KIX
and ABDs of Med15 (Fig. 2E). No such pattern has been observed in
studies probing the interaction of defined Gcn4 and Med15 domains
simply because the Gcn4 bZIP domain was not present [44]. One
(caption on next page)
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intriguing interpretation is that the Gcn4 activation and bZIP domains
are colocalised at the Med15 binding interface, which could only result
from some unexpected extension of the Gcn4 N-terminal activation
domain away from the DNA towards the C-terminal end of the bZIP
coiled-coil domain. Further structural studies of Med-PIC with Gcn4
bound upstream will be required to further address such mechanistic
questions. Although the “fuzzy” nature of the Gcn4-Med15 interface
would make high-resolution studies of Gcn4-Tail interactions extremely
challenging, many important questions could be addressed by visua-
lising the interaction even at more modest resolutions. For example,
such reconstructions could help address whether bending of the up-
stream DNA is required to bring bound activators in range of
interactions with the Tail module. Even in the “Tail-Up” state, Med15
was found to be spaced roughly 80 Å from the site of Gcn4 DNA binding
meaning that DNA bending or further Tail motion could well be in-
volved in bringing Gcn4 and Med15 together.
4. Practical approaches to integrative modeling of the
transcription initiation machinery
4.1. Cross-link mass spectrometry and the modularity of the proteome
While integrative structure determination (ISD) aims to utilize as
much experimental data as possible, in recent practice, CLMS, alongside
Fig. 3. Cross-linking MS guided integrative structure determination. (A) Cross-linking coverage plays a key role in determining how precisely a model component can
be localized. Med2 and Med3 both have numerous inter-protein cross-links constraining their N-terminal regions in the Mediator model (represented on bottom panel
by grey lines on blue schematics), yet none were found after the first 130 residues. Coarse grained beads representing 40 residues of Med 2 and 3 are localized in the
final model with RMSF precision between 10 and 20 Å from the N-terminal region (blue shades in upper heat map representation). Beyond this, the precision rapidly
deteriorates (red regions of heat map). (B) Cross-linked peptides can only be measured by a mass spectrometer if the precursor ion is successfully selected for
dissociation and product ion analysis. Tryptic digests of large, purified protein assemblies contain hundreds of peptide ions co-eluting from the nano-LC column at any
given moment even after fractionation to enrich for cross-linked peptides. The upper panel shows the total ion current corresponding to a single fraction of a size
exclusion chromatography-based cross-link enrichment. The precursor ion scan (MS1) taken at 59min shows hundreds of ion signals co-eluting. Cross-link identi-
fication requires isolation of the quintuple charged precursor ion at 532.31m/z for gas phase dissociation and measurement of the product ion (MS2) spectrum. Factors
influencing whether the cross-link will be identified include: the scan rate of the mass spectrometer, the extent of enrichment/fractionation in the 1st- chromato-
graphic dimension, the peak capacity and gradient length in the 2nd-chromatographic dimension, and the ionization efficiency of the cross-linked peptides and their
intensity relative to co-eluting peptides. (C) After measuring a cross-linked product ion spectrum, successful identification requires sufficient product ion formation to
identify both members of the cross-linked peptide pair. The upper and lower panel show the best and second-best hits to a cross-linked product ion spectrum after a
database search. The correct hit, corresponding to an intra-protein cross-link on Rpb1, differs from the incorrect hit, a potentially more interesting inter-modular cross-
link between Rpb1 and Med1, by a single blue y3-ion. In both cases, almost all of the product ion signals are matched to the sequence (green lines), with the longer, red
peptide accounting for most of these. (D) Mapping cross-links to existing high-resolution structure provides one method of validating a dataset. Common reagents such
as BS3 and DSS leave a suberate bridge between adducted lysine residues. To account for the flexibility of the lysine side-chain, distances are measured between Cαs,
giving an expected span of about 25 Å. In practice, 30 or 35 Å is typically used as the violation distance to account for protein dynamics and uncertainty in the
structural coordinates. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 4. Exploiting structural modularity and data
transferability. The assembly is a stable aggregate of
individual macromolecules (circles), organized into
modules (blue, yellow, green and coral colours). (A)
The architectures of two functional states of the
same assembly are related by a global conforma-
tional change which rearrange the modules without
significant perturbation of their internal structure.
The two functional states are for instance obtained
by varying the composition of the two samples.
Functional state A is used to derive a low-resolution
3D density map, by cryo-EM experiments (grey cir-
cles), while functional state B is utilized to collect
CLMS data, which can be grouped into intra- and
inter-module cross-links (coloured lines). (B) If the
target of the modeling is the structural determina-
tion of the functional state A, the different proteins
and components belonging to the modules are at-
tributed to the corresponding regions of the 3D
density map, after a suitable segmentation of the
density (black lines). (C) To allow the violation of
the inter-module distance restraints, two different
unknown weights are attributed to the inter- and
intra-module cross-links (dashed and continuous
lines, respectively), which were collected for func-
tional state B and transferred to functional state A.
The weights are determined during the modeling,
using the Bayesian scoring function. (For inter-
pretation of the references to colour in this figure
legend, the reader is referred to the web version of
this article.)
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cryo-EM, has become one of the pillars on which structural studies of
multiprotein assemblies rely. Bifunctional molecules are reacted with a
protein complex and the sites of adduction in the resulting peptides are
characterized by mass spectrometry [92–94]. CLMS can generate
thousands of pairwise distance relationships (“cross-links”) from pur-
ified macromolecular assemblies, typically requiring 10–200 µg of
starting protein complex. The current popularity of CLMS comes from
the development in the last 10 years of robust experimental protocols to
enrich cross-linked peptides [95,96], more sensitive mass spectrometers
with higher resolving power and faster scan rates [97], bioinformatic
algorithms capable of addressing the quadratic increase in search space
in large-scale cross-linking experiments and reliably estimating error
rates [98–100], and scoring functions to encode cross-link derived
spatial restraints and evaluate them against three-dimensional struc-
tural models [101]. CLMS experiments can generally be performed on
the same sample preparations used in cryo-EM and do not require any
additional genetic manipulations or isotopic labelling that might be
necessary for FRET, NMR, or proximity labelling MS, alternative ex-
perimental techniques to provide pairwise distance constraints at var-
ious resolutions. Recent developments make use of gas-phase cleavable
cross-linking reagents in conjunction with multiple rounds of ion iso-
lation and dissociation in the mass spectrometer [102,103] to perform
CLMS experiments on cellular or organelle level preparations
[104,105]. Hence, our ability to identify cross-links confidently by mass
spectrometry is not limited by the complexity of the sample prepara-
tion, although deriving meaningful structural models from extremely
heterogenous mixtures, such as a nuclear preparation [106], remains
conceptually unaddressed. A complete review [92–94] or protocol
[107] for performing and analysing CLMS experiments is outside the
scope of this manuscript, and has been covered elsewhere. This section
instead will focus on sometimes overlooked nuances and considerations
involved in preparing cross-linking datasets for ISD.
Cellular organization is modular and hierarchical [108,109]. Hence,
individual polypeptide chains are frequently found bound together only
in highly stable complexes. At the next level of organization, these core
complexes interact with other core complexes in more dynamically
regulated ways to assemble functional protein machines. Protein ma-
chines interact with each other through ever more transient and fleeting
interactions. Transcriptional initiation perfectly illustrates this premise
in the way that stable core modules, such as Mediator Head, Middle,
Tail, RNAPII, and TFIIK must all physically interact in a coordinated
fashion to convey the action of a gene activator binding at an enhancer
into a regulatory signal initiating the escape of pol II from the promoter
and the onset of mRNA synthesis. This modularity has several im-
plications for CLMS experiments. First, giant macromolecular targets
can be built up in a bottom-up fashion from experiments on smaller
core complexes. For instance, our work on the Med-PIC, made use of
and integrated all previously published CLMS experiments on many of
its subcomponents, including TFIIH [16], core initiation complex [110],
PIC [111], and our work on the Mediator [17], to assemble a combined
CLMS dataset of ∼2500 unique cross-links. In many cases, the struc-
tures of the core modules will remain fixed, with conformational
changes taking place at the interface of the modules. Hence, it is useful
to distinguish between intra-modular and inter-modular cross-link re-
straints, as their transferability to other systems can reasonably be ex-
pected to differ based on this classification. An example of how inter-
modular and intra-modular cross-link restraints were scored differently
in the Mediator complex modeling is given below (Section 4.5).
Secondly, higher order interactions at the interface of two modules
are by definition, more transient, and hence more difficult to capture by
covalent cross-linking approaches. For instance, we’ve observed that
inter-modular cross-links comprise only 8–18% of the total data in the
Med-PIC experiments. This is of course, unfortunate, since inter-mod-
ular cross-links tend to be the most novel and important in terms of
elucidating new structural biology. One route towards improving the
yield of inter-modular cross-links might be in using cross-linking
reagents with quicker labelling kinetics that can capture more transient
states of the assembly. Typical cross-linkers are activated esters, which
acylate protein-based nucleophiles, such as the ε–amino group of lysine.
The kinetics of the acylation reaction can be modulated by changing the
leaving group of the cross-linking reagent. For instance, changing the
leaving group of the commonly used cross-linking reagent dis-
uccinimidyl suberate (DSS) from N-hydroxy-succinimide to 1-hydroxy-
7-azabenzotriazole in the SBAT reagent, increases the rate of reaction
seven-fold and additionally produces a greater ratio of cross-links to
non-productive dead-end modified peptides [112]. Another approach to
increasing the yield of inter-molecular cross-links is to employ a two-
step cross-linking strategy. Substoichiometric formaldehyde is first ap-
plied to fix the system in a reversible cross-linking step, followed by
cross-linking with an irreversible reagent such as DSS or SBAT. The
formaldehyde fixation is reversed during work up, similar to chromatin
immunoprecipitation (CHIP), and the remaining cross-links analysed as
usual. Our pilot experiments with the Holoenzyme and Med-PIC com-
plexes showed a 10–50% increase in the number of cross-links when
preceded by a formaldehyde pre-fixation step (Trnka – unpublished
results), although these increases were not limited to inter-modular
cross-links and the effect has not been fully explored.
4.2. Which Residue-residue contacts are experimentally observable by cross-
linking mass spectrometry?
While CLMS is occasionally referred to inaccurately as an unbiased
sampling of distance restraints, in reality a number of factors influence
the sparseness of cross-linking data sets and whether a cross-link is
detectable by mass spectrometry? In order to observe a cross-link, (1) a
pair of reactive residues must reside in the protein assembly within: the
geometric span that is accessible to the cross-linking reagent, a tem-
poral span consistent with the kinetics of covalent capture, and a local
chemical environment that is favourable to the conjugation reaction,
(2) each of the container peptides must have physio-chemical proper-
ties that are amenable for mass spectrometry analysis, (3) the precursor
ion of the cross-linked peptide must have enough signal intensity for it
to be selected for dissociation by data-dependent MS sampling schemes,
(4) each of the cross-linked peptides must produce sufficient product
ions to unambiguously assign their identity.
There are an endless number of variations that can be made to the
chemistry of cross-linking reagents to address the first consideration.
For instance, cross-linking molecules can be designed with varying
bridge lengths, reaction kinetics, membrane permeability, or target
specificity [113]. However, there are some inherent limits imposed by
the protein assembly itself. The target amino acids must also be solvent
accessible and available for reaction. The reactivity of a lysine residue
targeted by a typical NHS-ester reagent is dependent on hydrogen
bonding and the local pH at that site. There is a wide range in a lysine’s
inherent reactivity depending on the extent to which it is protonated or
hydrogen bonded and it is common to see that cross-links are con-
centrated at a smaller number of highly reactive lysines that cross-link
to multiple other sites. Modulating the amino acid specificity of a cross-
linking reagent to target acidic residues [114] provides one route
around this issue, although this can considerably complicate the ability
to localize the cross-link to a particular residue based on its product
ions (“site-assignment”) as well as increasing the complexity of the
reaction mixture and lowering the cross-linking yield. The secondary
structure of the target protein influences the outcome of cross-linking as
well, with cross-links most likely to occur at loops and helices with
fewer cross-links observed from beta-sheeted regions. For our Med-PIC
study, comparing the distribution of predicted secondary structure at
the adducted residues against that of all residues shows helical cross-
links as 121% the expected amount, loop cross-links at 97% expected,
and sheeted cross-links at 41% expected.
Secondly, certain peptides are more likely to be measured during a
typical proteomics experiment. Peptides with length between
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approximately 5 and 30 residues and bearing some positive charge are
ideally detected by reverse-phase chromatography coupled online to
positive mode electrospray ionization and fragmented by collisional
dissociation. Hence, trypsin has always been the ideal protease for
proteomics experiments as the distribution of lysine and arginine re-
sidues generates favourable peptides. The use of other enzymes, such as
chymotrypsin, Asp-N, or Glu-C may provide some complementary
cross-link coverage for difficult to access regions, but in general these
enzymes do not provide such favourable peptides for mass spectrometry
analysis and comparative studies have not seen much benefit [96].
Namely, these enzymes tend to create peptides that are too short and
are hard to identify unambiguously, or else peptides with little positive
charge that do not ionize well. There is additionally a nice interplay
between trypsin selectivity and lysine-directed cross-linking, in that
modification at lysine by the cross-linking molecule blocks trypsin
cleavage, ensuring that most cross-linked peptides will only have one
likely site of modification. A mass spectrometer can also be tuned for
peptides that do not match the criteria listed above. For instance ne-
gative ion mode can be used for acidic peptides, or mobile phases can
be altered to favour hydrophobic or membrane spanning peptides. In
practice, most mass spectrometry facilities are highly oversubscribed
and changing the operating procedures of a major instrument places a
burden on the available resources.
Third, MS-proteomics are typically conducted in data-dependent
acquisition (DDA) mode. There are typically many more peptide ions
eluting at a given time from the LC-column than can be isolated, dis-
sociated, and measured (Fig. 3B). Therefore, DDA mode programs the
instrument to select ions based on certain criteria, such as ion intensity
and charge state. In some cases, DDA mode can select for the presence
of a pattern of ions that is characteristic for cross-linked peptides, such
as a pair of ions separated by a defined mass difference due to the use of
isotopically heavy and light versions of a cross-linking reagent [115].
Of the four aspects required to detect a cross-link, this is the most easily
modified or optimized. Cross-linked peptides can be enriched by size-
exclusion chromatography [96], cation exchange [95], or by affinity
tags in the reagent [116] or the protein complex of interest [24]. Fur-
thermore, the reverse phase chromatography that is directly coupled to
the mass spectrometer can be optimized for longer gradients using
longer packed or monolithic columns [18]. DDA analysis for cross-
linked peptides typically programs mass spectrometers to exclude
singly and doubly charged precursors to focus on cross-linked peptides
which tend to be quadruply charged or higher. Cross-linking chemis-
tries can be employed that increase the charge state further still
[117,118] for improved targeting of cross-linked versus linear peptides.
An exciting development is the recent increase in coupling of ion mo-
bility separation (IMS) with mass spectrometry [119,120]. IMS pro-
vides a millisecond scale separation of ions in the gas phase based on
collisional cross-section and hence charge-state and promises to provide
a route to further enrichment and isolation of cross-linked peptides.
Finally, cross-linked peptides, after being isolated for dissociation,
must produce enough product ions such that search algorithms can
identify both of the cross-linked peptides [100]. Collisional based dis-
sociation methods produce fragment ions according to mobile proton
theory [121] and whether product ions from both peptides are observed
largely depends on the gas-phase basicities and charge distributions of
the peptides. In cross-linking-MS, a common situation is that the pro-
duct ion distribution identifies one peptide very well, but leaves the
second peptide poorly identified. Gas-phase cleavable cross-linking re-
agents circumvent this problem by containing low-energy bonds that
dissociate prior to the peptide backbone during MS2. Subsequent iso-
lation of the individual peptide ions and a second round of dissociation
in MS3 provide fragmentation information for each peptide [102,103].
This approach provides both the individual precursor masses for each
peptide as well as their fragmentation patterns and can aid in correctly
identifying the peptides in the cross-link. In practice, these schemes
have inherent trade-offs such as an increased mass spectrometry cycle
time resulting in fewer cross-linked precursors being sequenced, as well
as insufficiently specific chemistry in MS2 leading to inefficiencies in
targeting the correct precursor ions for MS3. Electron-transfer dis-
sociation (ETD) is an alternative to collisional activation which shows
less specificity to the physicochemical properties of the peptide analytes
[122]. Efficient electron transfer to begin the dissociation process re-
quires positively charged peptide substrates, so that ETD should be the
ideal method for sequencing of positively charged, cross-linked pep-
tides to give an equal distribution of product ions from both peptides.
This method was infrequently applied however until recently, because
ETD implementation has consistently lacked in speed and sensitivity to
collisional methods. However, newer implementations [123] are
changing this situation and ETD is likely to become the method of
choice for cross-linking analysis.
4.3. “Noise” in cross-linking data sets and implications for ISD
In practice, cross-links are never identified completely un-
ambiguously. For any non-trivial-sized search space, a given spectrum
will match to multiple theoretical cross-linked peptide pairs that are
within the m/z tolerance of the precursor ion. These matches need to be
discriminated on the basis of how well the experimentally observed
product ions are explained by the theoretical cross-linked peptides.
Typically, the matched product ion series are incomplete, and the ex-
perimental spectra are noisy and contain product ion signals that come
from either co-eluting peptides with similar precursor m/z or otherwise
cannot be explained by the cross-linked peptide sequence. Especially for
short peptide sequences that are four or five residues long, multiple
proteins in a database might contain either identical or isomeric ver-
sions of these peptides that differ only in the arrangement of amino acid
residues. In these cases, the correct cross-linked peptide match can
sometimes differ from the next best match by only a single additional
product ion match (Fig. 3C).
Various metrics describing the match of the theoretical cross-linked
sequence to the experimental spectrum are reported by proteomics
search engines along with an overall statistically-derived classification
score. Hence, like other MS proteomics datasets, cross-linking data are
expected to contain misidentifications. Datasets are reported alongside
a false discovery rate (FDR), which is commonly based on conducting
the search against both the target protein sequences and randomized,
decoy versions of the same proteins [124]. For this approach to accu-
rately estimate the chance of a false match, a large enough decoy da-
tabase must be used to reliably model the distribution of incorrect hits.
Hence, the typical proteomics approach of using a decoy database equal
in size to the target database is not appropriate for small database
searches containing a limited number of protein sequences. In our
Mediator studies, we used a decoy database that was 10x larger than
the target database, making the total number of protein sequences
searched ∼700.
Additional validation of cross-linking data comes from mapping the
identified cross-links onto the atomic structures (when available) for
components of the complex. The distance between Cα atoms of the
cross-linked residues should be consistent with the length of the cross-
linker bridge group plus the length of the adducted amino acid side
chains. An additional 5–10 Å are typically added on top of this to ac-
count for imprecision in the atomic coordinates and dynamic motions
in the protein complex. Hence BS3 or DSS cross-links are generally
considered “violations” when the Cα -distance exceeds a limit of 30 or
35 Å, which includes the suberate bridge (∼12 Å), the length of two
lysine side chains (∼12 Å), plus an addition 5 or 10 Å (Fig. 3D). The
violation rate for a cross-linking dataset is often similar in value to the
FDR. However, the FDR formally describes the proportion of reported
residue pairs that are incorrectly assigned, whereas there are a number
of other reasons why violations may occur. These involve deviations
from the expected crystal structure either due to a conformational or
configurational discrepancy between the sample being cross-linked and
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the structural model used for assessment. Therefore, a violation rate
that is substantially higher than the FDR can indicate either a dis-
crepancy in the conditions used to obtain the different types of struc-
tural information, or a broader problem such as protein aggregation
under the cross-linking conditions.
With respect to utilizing cross-linking derived restraints in in-
tegrative modeling procedures it is important to realize that cross-
linking data are expected to contain incorrect or otherwise inapplicable
restraints, and that the probability of an individual restraint being in-
correct is reflected in a classification score, which can be passed on to
the modeling parameters. In this way, cross-links with more certain
assignments can be weighted more strongly than others. One aspect of
experimental mass spectrometry data that can be taken advantage of is
that there might be multiple lines of evidence supporting the assign-
ment of some cross-links. A CLMS experiment generates between
thousands and hundreds of thousands of product ion spectra that are all
searched for potential cross-links. Spectra that match above some
classification threshold are termed Cross-linked Spectral Matches
(CSMs). CSMs match a cross-linked peptide pair, and the cross-linked
peptide pair identifies a cross-linked residue pair (“cross-link”). Hence a
given cross-link is often identified by multiple cross-linked peptide
pairs, which are identified by multiple CSMs. It is important to note that
this redundancy derives not only from picking the same precursor
multiple times over one or more experiments, but from redundancy in
the chemical entity identifying the cross-linked residues. For instance,
cross-linked peptides can be identified from differently charged pre-
cursor ions, or one or both of the peptides might differ with respect to
the length of the peptide (due to missed enzymatic cleavage), with
oxidation state at methionine residues, or due to the presence of a
“dead-end” modification (in addition to a missed cleavage). These
factors will produce different precursor ions at different m/z values
with different product ion spectra. Hence, cross-links identified from
multiple cross-linked peptides have multiple lines of evidence pointing
to their existence. Cross-links identified from multiple CSMs however,
are not necessarily more confidently identified as the search algorithms
are deterministic so that incorrectly identified CSMs will be identified
consistently leading to redundant incorrect CSMs.
4.4. Treatment of the input data for ISD
The first stage of the ISD approach consists of gathering all the
available data needed to build the model and validate it. Spatial in-
formation about a given system can include data from a variety of ex-
periments, statistical propensities extracted from known homolog se-
quences or protein structures, and physical laws, such as atomic
interactions obtained from a molecular mechanics force field [46]. In
our approach input data include the sequences of the subunits and their
stoichiometry, the available atomic structures of domains, subunits or
subcomplexes, CLMS data with the identification frequency and iden-
tification scores of the cross-links, low-resolution cryo-EM density maps
of the complex, EM-labeling or EM-deletion experiments, and protein-
protein interactions from affinity purification and yeast two-hybrid
assays. All the input information is used to build the representation, the
scoring function, and the validation toolbox for the system. First,
crystallographic structures of the subunits and homology models are
used to build the representation. Second, the cross-linking data and the
EM density data, the sequence connectivity and physio-chemical data
are used to build the scoring function, third, data which are difficult to
encode in a scoring function are left out of the modeling procedure and
used for validating the final model.
For integrative modeling of the 21-subunit Mediator complex [17],
which will form the basis of discussions in Sections 4.4–4.9, the data
included:
(1) 298 Mediator cross-links identified from 1900 spectra, consisting of
multiple peptide sequences, charge states, or replicates.
(2) The atomic structures, including X-ray crystallography structures
and homology models, covering 80% of the Mediator Head module,
and overall 23% of the residues in the Mediator complex. It is im-
portant to note that whilst the resolution of the output models is
influenced by the coverage of atomic structures, a large percentage
of atomic structure is not required to produce a descriptive ISD
model. Early ISD models for the nuclear pore complex did not
contain any atomic structures [125] and the coverage for the
Mediator [17] and SEA complexes (35% coverage) [126] were both
very low.
(3) An 18 Å resolution cryo-EM density map of the Mediator complex
was used to constrain the overall-shape of the complex.
(4) Validation data, such as yeast two-hybrid, immuno-precipitation,
subcomplex isolation assays, and protein localization from labeling
and domain deletion EM studies. The validation data was not di-
rectly used in the modeling, but a posteriori, to assess the quality of
the models.
All the modelling protocols were scripted using the Python
Modelling Interface (https://github.com/salilab/pmi) [15], a library to
model macromolecular complexes based on the open source IMP
package (http://salilab.org/imp/) [46]. Files containing the input data,
scripts, and output models are available at a free repository, see for
instance http://salilab.org/mediator and https://zenodo.org/record/
802915.
4.5. System representation and scoring function development for ISD
The computational representation of a macromolecular system is
the collection of all the degrees of freedom that need to be determined
based on input information [14]. The representation assigns the system
components (e.g. residues, atoms or domains) to geometric primitives
with 3D coordinates (e.g. points, spheres or 3D gaussians) needed to
compute the score (Fig. 1). This assignment is decided before any other
computations, and is fixed along the computation. Recently, protocols
to optimize the molecular representation have been introduced [127],
where the optimum is the representation with the highest resolution for
which sampling is still exhaustive and the models have a precision that
is commensurate with the precision of the representation. The radius of
the spheres and the variance of the Gaussians were set to describe the
average molecular volume and the molecular electron density of poly-
peptide segments, respectively. The representation also uses rigid
bodies, where the relative positions of the primitives (e.g. residues in a
domain) are constrained based on a crystallographic structure. We use
coarse-grained beads to encode the uncertainty related to the degrees of
freedom of protein regions which are not directly represented by ato-
mistic structures in the input data. These coarse-grained beads are free
to move as spheres on a string, as opposed to the rigid-bodies, and are
connected based on the amino acid sequence. The resolution of the
coarse graining is commensurate with the resolution of the input in-
formation, in our case the cross-links and the cryo-EM density map. As a
consequence, the representation is multi-scale, where different parts of
a structure are represented by different coarse-graining levels. This
strategy maximizes computational efficiency while avoiding model
oversimplification.
In our modeling approach we used three scales to represent the
system where the rigid-bodies are defined: the first is where each bead
corresponded to individual residues, and was centered at the position of
the Cα atom, the second is where each bead represented 10-residue
segments and was positioned on the center of mass of all atoms of the
corresponding segment, and the third scale is the Gaussian mixture
model (GMM) approximation of the electron density of the corre-
sponding structure [128]. We adopted a two-scale representation for
the flexible strings: the first is where each bead represented either a 20-
or 40-residue segment and was positioned on the center of mass of all
atoms of the corresponding segment. The second is a spherical
M.J. Trnka, et al. Methods xxx (xxxx) xxx–xxx
12
Gaussian. In this case the bead and the Gaussian centers were enforced
to be identical.
The gathered data and the representation are next used to build a
scoring function, which ranks alternative models based on how well
they quantitatively reproduce the input data [129]. In our approach,
the scoring function computes: (1) the excluded volume to avoid cla-
shes between distinct residues/domains, (2) the quality of the covalent
connectivity of the polypeptide chains, (3) the agreement with both the
cryo-EM density map and with the CLMS data. Also, the scoring func-
tion takes into account the uncertainty of the input information, and
encodes the presence of modularity and whether some data was
transferred from another macromolecular sample. In our approach we
prefer a Bayesian formulation of the scoring function [130], which is
more objective than traditional scoring functions. This formulation can
infer unknown quantities, combine different types of information and
account for noise in the data. This is particularly important for the
treatment of CLMS data, were some assignments might be erroneous.
The Bayesian scoring function is proportional to the posterior
probability p(M|D,I) of a model M given the gathered data D and prior
information I. The model M≡ (X,{αi}) includes the structural co-
ordinates X and additional parameters {αi} which describe unknown
attributes of the data such as the noise or the relative weight of distinct
data pieces. Using Bayes' theorem, the posterior probability is p
(M|D,I)∝ p(D|M,I)p(M,I), where the likelihood function p(D|M,I) is the
probability of observing data D, given I and M, and the prior is the
probability of model M, given I. The likelihood function for the CLMS
data was built from a “forward model” that predicts the formation of a
cross-link given the coordinates of a structural model, and a “noise
model” that quantifies how much we can tolerate an error of the model
(e.g. a cross-link that was observed and reported in the dataset which is
not predicted to be formed in the model) [17,24,101]. Finally, the joint
likelihood function p(D|M,I) for a dataset D = {dn} of NXL in-
dependently observed cross-links is the product of likelihood functions
for each cross-link. Both the functions of the forward and the noise
model introduce parameters to describe uncertainty. In particular, the
likelihood function uses ψ, which is the unknown uncertainty that a
cross-link is correctly assigned and regulates the weight of the corre-
sponding restraint.
Importantly, the CLMS data was collected on a sample of Med-
RNAPII Holoenzyme and transferred to the Mediator system lacking
RNAPII. The addition of RNA pol II is observed to induce motions at the
junctions between Mediator modules, while the intra-module topology
appears unchanged [48,131]. As a consequence, we expected the inter-
module cross-links to be less accurate than the intra-module cross-links
in describing the apo-Mediator state. To account for transferability and
modularity, we assigned the inter- and intra-module cross-links, re-
spectively 8% and 92% of the total, to different classes that were fit
with different values of ψ (Fig. 4C). In this way we lessen the impact of
inter-module cross-links while benefitting from intra-module ones.
Finally, the scoring function for the cryo-EM data was computed
based on the Gaussian Mixture Model (GMM) representation of each
domain, using the cross-correlation coefficient between GMM re-
presentations of the EM volume and model components [17]. The
weights of each GMM component were normalized to the relative mass
of the component vs the mass of the module. We exploited the mod-
ularity by dividing the EM density map into segments reflecting the
Head, Middle and Tail module on the basis of previous approximate
localization of subunits within two distinct regions of the EM map
[70,71] (Fig. 4B). During modeling, each Middle or Tail subunit density
was restrained to the corresponding Middle or Tail EM density seg-
ments. The Head module was kept fixed in its initial docked position,
except for the sections that were not resolved in the crystal structure
and therefore present as coarse-grained representations. Recently, a
Bayesian scoring function based on the GMM approach was developed,
allowing an objective weighting of the EM density data with respect to
the other information [128].
4.6. Exhaustive configurational sampling with replica exchange
One important requirement for the ISD approach is the generation
of an exhaustive sampling of the model. To achieve this goal, we have
to adopt improved sampling schemes and carry out a large number of
independent sampling runs. In each run the positions and orientations
of rigid bodies and flexible strings of beads, and the values of free
Bayesian parameters, are randomly and iteratively perturbed in an ef-
fort to satisfy and optimize the scoring function, based on the
Metropolis Monte Carlo algorithm. The improved sampling protocol
followed the Replica Exchange scheme [130], using 64 replicas, with
temperatures ranging between 1.0 and 2.5. The Replica Exchange
scheme enhances the sampling by allowing hopping between alter-
native minima of the scoring function, thus preventing the sampling
from becoming stuck in local minima. To confirm that we had sampled
conformational space sufficiently to reach model convergence, we
compared two independent halves of the solutions to each other and to
the entire set, and assessed whether they display similar structural
features. If we couldn’t find a satisfactory agreement, we double the
number of sampling runs, until convergence. For the Mediator mod-
eling, the exhaustive sampling produced a total of 165,523 models in
20 independent runs. In a recent paper, an automated convergence
protocol was proposed with a series of statistical tests [132], which are
more objective and stringent.
4.7. Model assessment and clustering in ISD
Integrative structural determination eventually results in clusters of
individual models that best satisfy the input constraints. To identify
these clusters, analysis is carried out on a small fraction of the models
representing the very best scoring solutions. First, the 500 best scoring
models (the solutions) are selected from the whole sampled ensemble
and checked for whether they satisfy the input restraints. Second, the
solutions are clustered by structural similarity using the root mean
squared distance (RMSD) of the beads as a structural metric. The
number of clusters is set to be the most parsimonious number that se-
parates the main structural differences between all the solutions.
Finally, the representative cluster(s) are selected according to their
score, or alternatively the agreement with data that was not used in the
scoring function (the validation data).
In the case of the Mediator, the solutions were grouped into four
main clusters, with distinct structural properties. Clusters 1, 2, and 4
had the Middle module oriented in the expected orientation (i.e., Med1
and Med19 were at the bottom and at the top of the module, respec-
tively). The three clusters differ in the arrangement of the Tail subunits.
Cluster 3 had the Middle module in a ‘flipped’ orientation (i.e., Med1
and Med19 are at the top and at the bottom of the module, respec-
tively). All the solutions from all clusters satisfied excluded volume,
sequence connectivity, and EM restraints. Since the CLMS dataset was
transferred from the Holoenzyme sample, not all the cross-links were
satisfied. In fact, while 95% of intra-module cross-links were fulfilled,
only a small portion (10%) of inter-modular cross-links were satisfied.
The Bayesian scoring function automatically down-weighted the inter-
modular cross-links to satisfy the EM restraint, pointing to an incon-
sistency of the inter-modular cross-links in the Holoenzyme dataset
with the EM density map of the free Mediator. The satisfaction of intra-
modular cross-links suggests that the arrangement of Mediator subunits
within each module of the Holoenzyme retains the main characteristics
to that in the free Mediator. Since the average scores of the different
clusters were only marginally different, it was not possible to rank the
clusters and identify the configuration which best fit the input data.
Therefore, we used the validation data, and in particular the EM loca-
lization experiments, to choose the representative cluster. Remarkably,
only Cluster 1, which also happened to be the top-scoring cluster, was
fully in agreement with all EM localization experiments.
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4.8. Calculating precision of the solution, subunit density and subunit-
subunit proximities in ISD
The degree to which a component of the model, either a coarse-
grained bead or residue, fluctuates across the ensemble of individual
models indicates how precisely localized that component is in the
modeling solution. We used several analysis metrics to represent the
global and relative localization of domains and compute their precision:
the localization density, the domain precision calculation, the root
mean squared fluctuations (RMSF), and protein-protein contact ana-
lysis. First, for a given cluster of solutions, we computed the probability
of finding any residue of a given protein at any point in space (i.e., the
localization density map). The localization density is stored in a 3D
grid, similarly to a 3D density map obtained from cryo-EM data, and it
is a very convenient way to display the architecture of the whole
complex from an ensemble of solutions. All localization density maps of
proteins and domains are displayed in the software Chimera by an
isosurface [133], which in our case was obtained using a threshold of
0.15. The precision of a domain (or a protein, or the whole complex) in
a given cluster of solutions is calculated as the average RMSD between
the cluster center and all other solutions. The precision can be used to
compute the distance between two clusters, as the average RMSD on the
whole complex, between every pair of solutions taken from the two
clusters. The RMSF of a given residue is the standard deviation of the
set of distances between the position of the residue in each solution of
the cluster and its position in the cluster center.
As might be expected, there is a strong relationship between the
number of consistent cross-links restraining a given bead and its loca-
lization precision. For instance, numerous cross-links were detected at
the N-termini of Mediator Tail module subunits Med2 and Med3, with
almost none at the C-termini. This was reflected in a RMSF near 10 Å for
the N-terminal regions along with a high level of confidence in placing
them at the junction between the Middle and Tail modules of Mediator
(Fig. 3A). In contrast, after the first 100 residues or so it becomes dif-
ficult to localize these subunits. This intuitive finding points to the need
to maximize the coverage of cross-links across the complex in question,
particularly in regions with little or no atomistic structure available.
Protein-protein contact analysis of the solutions in a cluster can be
carried out at the residue or domain level. In the former, the relative
contact frequency of a pair of residues is computed based upon how
often the two residues contact each other in the cluster, where a contact
occurs when the distance between the residues is less than 10 Å. In the
latter, two domains are in contact when the surface of any bead in one
domain is within 10 Å of the surface of any bead in the second domain.
Long sequences are divided into domains of 200 residues. Finally, the
residue and domain interaction frequency can be rendered in a heat
map that displays in a compact manner the propensity of contacts for a
given cluster of solutions. Some of these contacts result simply from the
identification of cross-links between the domains, however other con-
tacts emerge indirectly due to the identification of synergistic sets of
cross-links.
4.9. Model validation
The final and crucial stage of the whole ISD approach involves va-
lidating the models. Without validation, it is difficult to trust the
models, as they can arise from artefacts of the modeling procedure it-
self, such as overfitting. First, the ensemble of solutions of the selected
representative cluster is assessed in terms of how well it satisfies the
data from which it was computed, including the cross-links, excluded
volume, sequence connectivity and the three-dimensional EM re-
straints. This allows us to check the reliability of the modeling proce-
dure: if models partially satisfy the data, one might suspect under-
sampling, strong data inconsistency, or mistakes in the data-encoding in
terms of the scoring function [14]. As mentioned above, the Mediator
model fit the EM map, satisfied most of the intra-modular cross-link
restraints, and it was stereochemically sound since it satisfied the ex-
cluded volume and sequence connectivity. Second, we used a cross-
validation assessment using the CLMS dataset. In the cross-validation
approach, we assessed the ensemble of solutions by comparing it with
the ensemble of solutions obtained by jackknifing 10% the CLMS da-
taset in 34 different random ways. We compared the obtained locali-
zation maps, and computed the model precision to estimate the struc-
tural differences between clusters obtained using the whole CLMS
dataset and clusters obtained using jackknifed datasets. Strikingly, the
results were similar: both modeling approaches resulted in the same
number of clusters, with the same structural features. That result sug-
gested that the CLMS data was robust and accurate, and that the models
were not a mere result of overfitting. Third, we validated the models
based on unused data published in the literature. In fact, the Mediator
model was remarkably consistent with almost all data from previous
subunit interaction and subunit localization studies. The models ex-
plained subunit interactions inferred from co-expression [54,67,69],
pulldowns/immunoprecipitation [54,68], and yeast two-hybrid assays
[49,64,65] with only three discrepancies, which were clearly spurious.
Furthermore, the Mediator model was validated by comparison with
results from two-dimensional EM studies that used subunit labelling or
subunit deletions to map subunit locations. [70,71]. The model was
consistent with all these pieces of information, confirming the quality
and the predictive power of the structure.
5. Conclusions and future perspectives on integrative structural
techniques in the age of the Cryo-EM ‘resolution revolution’
Despite the success of cross-linking and low-resolution EM-derived
integrative models at inferring both global architectures and pseudo-
residue level structures of protein machines in recent years, there is a
seemingly diminishing role for these workflows in the current era
where high-resolution EM reconstructions of large protein complexes
are becoming increasingly prevalent. What is the value of an imprecise
model if we can seemingly wait another half year before an atomistic
structure is revealed? Is there room to improve the performance of
cross-linking based models? Since the precision of these models de-
pends upon both the distance defined by the cross-linking reagent as
well as the density of cross-links that constrain a given amino acid re-
sidue three-dimensionally, it should be possible to achieve more refined
integrative models using “zero-length”, carbodiimide based cross-lin-
kers [134] as well as by increasing the cross-linkable space with acid-
directed [114] or other cross-linking chemistries. One approach to the
latter aim is through using carbene generating, photochemical reagents
[135]. However, the extremely heterogenous reaction mixtures that
result from diazirine cross-linking make site-specific assignments of
photo-cross-linked residues by mass spectrometry technically challen-
ging and limit this approach. Recent attempts to utilize photo-cross-link
derived restraints to aid protein structural prediction in the CASP11
competition showed no benefit [136]. However, technical develop-
ments using zero-length cross-linkers may still provide a future avenue
to increasing the precision of cross-linking based structural inference.
Such improvements may well be important for the structural analysis of
protein complexes that continue to resist high-resolution EM re-
construction and thereby ensure that integrative modeling still has a
role to play in the near future.
What factors determine the resistance of a protein complex to high
resolution EM reconstruction? Even though cryo-EM has advanced
significantly, heterogeneity derived from non-discrete, continual mo-
tions of domains still provides a significant challenge to algorithms
designed to classify particles in 2- and 3-dimensions. This is especially
the case when more than one region of a large multi-subunit complex
displays continuous motion and the mobile regions represent a large
proportion of the mass of the complex [137]. Many biological systems
will be difficult to solve at atomic resolution for this reason and so the
combination of low-resolution EM with X-ray crystallography and
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cross-linking will still play an important role in these circumstances.
Some features of the Mediator complex that were first revealed through
our integrative model such as the connection between the N-terminus of
Med17 and the Middle module were later shown to be highly accurate
by high-resolution EM [75] and crystallography [76]. For other fea-
tures, our model remains the best description of Mediator available.
These include the Tail module which is highly dynamic, contains many
disordered regions, and participates in ”fuzzy” interactions with acti-
vators such as Gcn4 (see Section 3.6). Thus, a high-resolution EM re-
construction of the Tail module might not be possible with existing
technology, but ISD approaches can infer molecular features at pseudo-
residue level precision. For instance, our Tail module model predicts
specific structural features such as the N-terminal portion of Med5 ex-
tending across the β-propeller domain of Med16 to contact Med15 [17]
and associates a precision (RMSF value) with these predictions. Much of
the Tail module remains resolved at poor resolution in our model due to
lack of adequate cross-linking restraints. Hence, our structural under-
standing of the Tail module would likely be improved by the applica-
tion of cross-linking methodologies that increased coverage in these
domains.
In addition to the high frequency fluctuations of the Tail module,
our data suggest that it also undergoes a more coordinated rearrange-
ment upon PIC binding that places Med5 in contact with Med1 of the
Middle module (Section 3.6). This represents a more stable conforma-
tional heterogeneity that is resolvable by EM. CLMS can aid in under-
standing these states through the use of quantitative MS methods. For
instance, the Med-PIC can be cross-linked in the presence and absence
of Gcn4 using reagents with different isotopic signatures [138]. The
cross-linked samples are combined, prepared for mass spectrometry
analysis, where the isotopic ratio of cross-linked peptide precursors
reports on states that are enriched or depleted in the presence of Gcn4.
Quantitative CLMS (qCLMS) can be extended to multiple states along a
mechanistic pathway, such as promoter escape, through using multi-
plexed proteomics methods such as PRM [139] or TMT labelling [140].
Using such methods, sub-conformations of a protein assembly do not
need to be homogenous, as long as one state is enriched sufficiently to
be quantified by MS. Hence, these sorts of qCLMS approaches as inputs
to ISD might be useful in resolving more dynamic and heterogenous
populations of protein assemblies as well, although they do require that
the individual mechanistic states can be partially stabilized through
modulating the sample conditions, without significant changes to the
protein composition.
However, the true value of integrative models going forward lies not
in traditional structural biology, which focuses on elucidating stable
elements of macromolecular tertiary and quaternary structure, but as
tools to study the non-classical, sequence-independent and low-affinity
interactions known as “fuzzy-interactions” [141,142] and protein
quinary structure [143–145]. These emerging areas of study have been
implicated in transcriptional regulation through the binding of gene
specific activators to their co-activator targets in complexes without a
single ground-state conformation, and by governing the formation and
organization of cellular structures that sequester large ensembles of
transcriptional machinery in sub-nuclear, membrane-less compart-
ments. These processes are inherently conformationally dynamic and
heterogenous and thus not easily represented by single-state atomistic
molecular models that can be resolved by high-resolution EM or X-ray
derived techniques. Instead, we anticipate that multi-state representa-
tions of these systems will be accessible via extension of existing in-
tegrative modeling methodology. Experimentally, techniques that are
well integrated into integrative methods such as CLMS and mixed re-
solution EM will continue to play an important role, as will other
methods such as NMR [146,147], real-time immunofluorescence mi-
croscopy [148], proximity labelling-MS [149], and chemical foot-
printing-MS methods [150] such as hydrogen-deuterium exchange or
oxidative footprinting.
Quinary structure represents a fifth level of protein organization
based on transient and weak-affinity protein interactions [143]. These
fleeting interactions are difficult to capture experimentally, yet they
play a major role in organizing the intracellular environment at a scale
larger than a protein complex yet smaller than an organelle. For in-
stance, various multi-step metabolic pathways rely on the spatial co-
localization of multiple macromolecular complexes for efficient bio-
synthesis. Membrane-less compartments have been shown to form in
the nucleus to sequester molecules with related functions [151]. Ex-
amples include: Nuclear speckles, which contain mRNA splicing factors,
the Nucleolus, which contains ribosome synthesis machinery, and
super-enhancers, which bring together extremely high concentrations
of transcriptional machines including activators, co-activators and the
PIC, at promoters that seem to have particularly important roles in
regulating cellular differentiation and oncogenesis [40]. In lieu of
phospholipid membranes, these microenvironments are defined by the
oligomerization of multi-valent scaffold proteins that show a high
prevalence of intrinsically disordered domains with low sequence
complexity [152]. For instance, heterochromatin is dynamically se-
questered by the multivalent heterochromatin protein HP1α, which
contains two structurally disordered regions. Phosphorylation at one of
these domains regulates extension at the other to a conformation that
favours inter-HP1α interactions that act as a scaffold to condense and
isolate transcriptionally silent regions of the genome [153]. Membrane-
less compartments exhibit properties of liquid droplets, such as phase
separation and droplet fission and fusion [143]. While the free energy
of these interactions is weak (1 kcal/mol, an order of magnitude lower
than quaternary protein structure), the densely crowded cellular en-
vironment (200–400 g/L protein concentration) amplifies the chemical
forces exerted by neighbouring molecules through electrostatic, hy-
drophobic, polar, and hydrogen bonding interactions. Hence, small
chemical modifications can lead to large-scale re-organization of the
cellular microenvironment.
In addition to contributing to the characterization of membrane-less
compartments, ISD will also likely play an important role in under-
standing transcription complexes at higher levels of organization. In
addition to the Mediator-PIC assembly, numerous protein complexes
act at a gene promoter to influence its transcription. These include
other co-activators such as TFIID and SAGA as well as chromatin re-
modeling complexes such as SWI/SNF and RSC, and inhibitory modules
such as the Mediator Kinase module. How these complexes coordinate
their actions with the Med-PIC, the nature of their super-assemblies if
any, and how promoter identity influences mechanism are open ques-
tions. These larger assemblies represent a logical next step in continuing
our modular approach to ISD which builds models of increasingly larger
assemblies based in part on transferability of data acquired on smaller
subassemblies. However, unlike previous iterations of this process,
these larger assemblies are governed by quinary interactions. Super
enhancers are clusters of spatially proximate enhancers that regulate a
single promoter and contain elevated concentrations of Mediator, the
general transcriptional machinery and other co-activators relative to
regular promoters [40]. Various groups have proposed that super en-
hancers represent phase separated droplets which sequester high con-
centrations of transcriptional machinery at gene promoters of particular
importance to oncogenesis and determination of cellular fate
[41,42,154]. Mediator is enriched in super enhancers and antibodies
directed at Middle module subunit Med1, which contains a high portion
of low complexity domains, are used to characterize super enhancers in
ChIP-Seq or fluorescence imaging experiments. The organization and
composition of super-enhancers is very much unknown. For instance,
what is the nature of the scaffold that creates a phase-separated com-
partment and what are the client proteins? The stoichiometry of these
compartments is also unknown and likely to vary, and it is likely that
organization of the individual protein machines within the compart-
ment is governed by weak interactions with multiple modes of binding.
Hence, it is unlikely that EM will ever be able to produce a single,
atomistic ground state structure of a super-enhancer. However, ISD
M.J. Trnka, et al. Methods xxx (xxxx) xxx–xxx
15
approaches which describe biological systems probabilistically and can
address multi-state systems, can potentially be developed to model
super enhancers and other conglomerations of transcription complexes
in a way that yield clues as to the structural principles that influence
gene regulation. Since these complexes are good examples of quinary
structures that will be very labile in nature, integrative structural ap-
proaches will likely play a key role in advancing the structural biology
of these complexes, as it did in the emerging picture of the Mediator
complex and related transcription complexes.
The value of integrative models in the future is in addressing pro-
blems in structural biology that are not tractable by high-resolution
methods. These are problems involving heterogenous structures, highly
dynamic conformational fluctuations, intrinsically disordered domains,
“fuzzy”-interactions, and higher-order structures within a cell encom-
passing ensembles of transcription related protein complexes. These
areas comprise many emerging themes in transcriptional regulation,
and they challenge existing structural biology techniques and para-
digms which are best suited for stable, homogenous assemblies.
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